Position in PFE
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$229,078,867
-$33,345,609 QoQ
Shares Held
9,513,242
+1.8% QoQ
Ownership
0.167%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#61
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ENVESTNET ASSET MANAGEMENT INC holds $6,826,194,566 across 15 Drug Manufacturers - General names. PFE ranks #8 (3.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,175,866 | $1,410,369,073 | |
| 2 | JNJ |
Johnson & Johnson
|
4,910,996 | $1,247,245,654 | |
| 3 | ABBV |
AbbVie Inc.
|
4,886,670 | $1,229,681,638 | |
| 4 | AMGN |
Amgen Inc
|
1,689,843 | $611,925,947 | |
| 5 | MRK |
Merck & Co., Inc.
|
3,996,890 | $513,600,365 | |
| 6 | AZN |
Astrazeneca PLC
|
2,281,431 | $432,604,946 | |
| 7 | NVS |
Novartis AG
|
2,330,979 | $365,311,028 | |
| 8 | PFE |
Pfizer Inc
This page
|
9,513,242 | $229,078,867 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $229,078,867 | 9,513,242 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $262,424,476 | 9,345,601 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $215,337,714 | 8,648,101 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $255,556,068 | 10,029,673 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $271,368,739 | 11,195,080 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $263,589,543 | 10,402,113 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $243,301,775 | 9,170,817 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $287,229,963 | 9,925,016 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $287,076,674 | 10,260,067 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $278,088,771 | 10,021,217 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $231,174,487 | 8,029,680 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $274,558,273 | 8,277,307 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $250,891,456 | 6,840,007 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $326,997,679 | 8,014,649 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $300,968,234 | 5,873,697 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $273,742,386 | 6,255,539 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $306,815,169 | 5,851,901 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $240,479,001 | 4,645,142 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $261,860,768 | 4,434,560 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $213,225,300 | 4,957,575 | Shares | Sole | 2021-10-07 | |
| 2021-06-30 | $208,083,356 | 5,313,671 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $177,235,710 | 4,891,960 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $163,547,455 | 4,443,017 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $165,361,779 | 4,505,775 | Shares | Sole | 2020-10-09 | |
| 2020-06-30 | $146,560,570 | 4,481,970 | Shares | Sole | 2020-07-08 | |
| 2020-03-31 | $152,543,616 | 4,673,524 | Shares | Sole | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||